These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24011247)

  • 41. A modified bismuth-containing quadruple therapy including a short course of furazolidone for Helicobacter pylori eradication after sequential therapy failure.
    Fakheri H; Bari Z; Sardarian H
    Helicobacter; 2012 Aug; 17(4):264-8. PubMed ID: 22759325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study.
    Gu LY; Lin WW; Lu H; Chen XY; Ge ZZ; Li XB
    Helicobacter; 2011 Aug; 16(4):284-8. PubMed ID: 21762267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
    Zullo A; De Francesco V; Manes G; Scaccianoce G; Cristofari F; Hassan C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):131-4. PubMed ID: 20593044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Helicobacter pylori infection 2017.
    O'Connor A; Lamarque D; Gisbert JP; O'Morain C
    Helicobacter; 2017 Sep; 22 Suppl 1():. PubMed ID: 28891137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential therapy for Helicobacter pylori eradication: a critical review.
    Gisbert JP; Calvet X; O'Connor A; Mégraud F; O'Morain CA
    J Clin Gastroenterol; 2010; 44(5):313-25. PubMed ID: 20054285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.
    Kuo CH; Hsu PI; Kuo FC; Wang SS; Hu HM; Liu CJ; Chuah SK; Chen YH; Hsieh MC; Wu DC; Tseng HH
    J Antimicrob Chemother; 2013 Jan; 68(1):222-8. PubMed ID: 22984204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
    Kim SY; Lee SW; Hyun JJ; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Choi JH
    J Clin Gastroenterol; 2013 Jan; 47(1):21-4. PubMed ID: 22647826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.
    Chuah SK; Hsu PI; Chang KC; Chiu YC; Wu KL; Chou YP; Hu ML; Tai WC; Chiu KW; Chiou SS; Wu DC; Hu TH
    Helicobacter; 2012 Jun; 17(3):216-23. PubMed ID: 22515360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.
    Cammarota G; Martino A; Pirozzi G; Cianci R; Branca G; Nista EC; Cazzato A; Cannizzaro O; Miele L; Grieco A; Gasbarrini A; Gasbarrini G
    Aliment Pharmacol Ther; 2004 Apr; 19(7):789-95. PubMed ID: 15043520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.
    Lee SK; Lee SW; Park JY; Kwon BS; Kim SY; Hyun JJ; Kim JH; Jung SW; Koo JS; Yim HJ; Choi JH
    Helicobacter; 2011 Oct; 16(5):410-4. PubMed ID: 21923688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment for Helicobacter pylori: current criteria].
    Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
    Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.
    Polat Z; Kadayifci A; Kantarcioglu M; Ozcan A; Emer O; Uygun A
    Eur J Intern Med; 2012 Mar; 23(2):165-8. PubMed ID: 22284248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
    Wang Z; Wu S
    Singapore Med J; 2012 Apr; 53(4):273-6. PubMed ID: 22511052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
    Kuo CH; Hu HM; Kuo FC; Hsu PI; Chen A; Yu FJ; Tsai PY; Wu IC; Wang SW; Li CJ; Weng BC; Chang LL; Jan CM; Wang WM; Wu DC
    J Antimicrob Chemother; 2009 May; 63(5):1017-24. PubMed ID: 19246508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
    Perri F; Festa V; Clemente R; Villani MR; Quitadamo M; Caruso N; Bergoli ML; Andriulli A
    Am J Gastroenterol; 2001 Jan; 96(1):58-62. PubMed ID: 11197288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
    Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
    Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.